Ruane, Cunniff & Goldfarb’s Medtronic MDT Stock Holding History

Ruane, Cunniff & Goldfarb’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,000	Closed	-$242K	–	83
2017 Q1	$242K	Hold	3,000	–	–	﹤0.01%	85
2016 Q4	$214K	Hold	3,000	–	–	﹤0.01%	92
2016 Q3	$259K	Sell	3,000 -395	-12%	-$34.4K	﹤0.01%	97
2016 Q2	$295K	Sell	3,395 -500	-13%	-$40.4K	﹤0.01%	102
2016 Q1	$292K	Sell	3,895 -1,180	-23%	-$88.9K	﹤0.01%	123
2015 Q4	$390K	Hold	5,075	–	–	﹤0.01%	121
2015 Q3	$340K	Buy	5,075 +195	+4%	+$14.4K	﹤0.01%	126
2015 Q2	$362K	Hold	4,880	–	–	﹤0.01%	126
2015 Q1	$381K	Buy	4,880 +180	+4%	+$13.6K	﹤0.01%	126
2014 Q4	$339K	Sell	4,700 -5,000	-52%	-$347K	﹤0.01%	131
2014 Q3	$601K	Buy	+9,700	New	+$617K	﹤0.01%	113

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Ruane, Cunniff & Goldfarb's MDT Position: Q2 2017 in Review

Ruane, Cunniff & Goldfarb sold out of Medtronic (MDT) in Q2 2017, closing a stake of 3,000 shares — an estimated $242K sold.

Ruane, Cunniff & Goldfarb first reported a position in MDT in Q3 2014 and held it in 11 quarters. The position peaked at $601K in Q3 2014. 1,280 funds tracked by Wall St. Rank hold MDT as of Q2 2017.

Ruane, Cunniff & Goldfarb reported no remaining Medtronic position as of Q2 2017 after selling out during the quarter.
Ruane, Cunniff & Goldfarb sold 3,000 Medtronic shares in Q2 2017, an estimated $242K.
Ruane, Cunniff & Goldfarb first reported a position in Medtronic in Q3 2014 and held it in 11 quarters.
Ruane, Cunniff & Goldfarb's Medtronic position peaked at $601K in Q3 2014.
1,280 funds tracked by Wall St. Rank held Medtronic as of Q2 2017.

Based on Ruane, Cunniff & Goldfarb's 13F filing for Q2 2017, filed 14 Aug 2017.